4D PHARMA PLC (DDDD)

4D PHARMA PLC (DDDD)

Blog posts

Laggard DDDD – 4D Pharma placing with no Primary Bid individual offer

By Cliff Weight, ShareSoc Director. I hold shares in DDDD. I am not sure if I am happy or angry with 4D Pharma. Duncan Peyton (Chief Executive Officer) and Alex Stevenson (Chief Scientific Officer) have each subscribed £725,000 for shares in the placing, which in total raised £20m at a price of 110p. Their commitment and increased skin in the game is excellent and praiseworthy. The share price this morning is 118p. So those who invested at 110p have a modest gain of 7%. However ...

A Review of my Portfolio in 2020

By Cliff Weight, ShareSoc Director Please note I am not qualified to give investment advice, and nothing in this blog constitutes advice. Overview Chris Spencer Phillips reported in a recent blog https://www.sharesoc.org/blog/investment-strategies/a-review-of-my-2020-share-portfolio-chris-spencer-phillips/ that his portfolio was up +80% in 2020, after being + 25% in 2019. Congrats and hats off to Chris. I cannot rival that, but I thought readers might find my review of 2020 of interest. My portfolio numbers for 2020 were: Everything – all equities, ISAs, SIPPs, OEICS, etc       ...

Leaders and Laggards

Laggard DDDD – 4D Pharma placing with no Primary Bid individual offer

By Cliff Weight, ShareSoc Director. I hold shares in DDDD. I am not sure if I am happy or angry with 4D Pharma. Duncan Peyton (Chief Executive Officer) and Alex Stevenson (Chief Scientific Officer) have each subscribed £725,000 for shares in the placing, which in total raised £20m at a price of 110p. Their commitment and increased skin in the game is excellent and praiseworthy. The share price this morning is 118p. So those who invested at 110p have a modest gain of 7%. However ...